drugset / Trial / NCT06019741
Rivaroxaban Post Coronary Bypass Surgery
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Post coronary bypass patients were randomized to receiving aspirin alone or aspirin and low dose rivaroxaban
Timeline
- Start
- 2021-02-01
- Primary completion
- 2022-05-01
- Completion
- 2022-07-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rivaroxaban | Other / unclassified | 2.5 mg | Oral |
| Comparator | Aspirin | Small molecule | 80 mg | Oral |